Oliver Robert L, Davis Julian R E, White Anne
Endocrine Sciences Research Group, Schools of Medicine and Biological Sciences, University of Manchester, Manchester M13 9PT, UK.
Pituitary. 2003;6(3):119-26. doi: 10.1023/b:pitu.0000011172.26649.df.
Adrenocorticotrophin (ACTH) is derived by cleavage from the precursor, pro-opiomelanocortin (POMC), and depending on the degree of processing by the tissue or tumor, there is the potential for a number of ACTH-related peptides to be secreted from POMC expressing cells. Previous chromatographic approaches have indicated the presence of high molecular weight forms of ACTH in the human peripheral circulation. However a quantitative assessment of the degree of processing requires two-site immunoradiometric assays which distinguish ACTH precursors and ACTH. Using this approach, we have previously identified the precursors of ACTH (POMC and proACTH) in the circulation of normal subjects in the range 5-40 pmol/l, which suggests that processing in the normal pituitary cell is incomplete. This study aimed to examine the extent of POMC processing by tumors that give rise to Cushing's Syndrome as a means of evaluating its usefulness as a diagnostic marker. In a retrospective analysis of 86 patients with Cushing's Syndrome, 34/35 patients with pituitary tumors had low levels of ACTH precursors (below 100 pmol/l) and the mean ratio of ACTH precursors:ACTH was 5:1 which indicates that these tumors do process POMC to ACTH relatively efficiently. In ectopic Cushing's Syndrome, it is unlikely that the extra-pituitary tumor cells, process POMC as efficiently. Therefore increased prevalence of ACTH precursors in the circulation would be expected and this was substantiated by the large excess of ACTH precursors (139-18,000 pmol/l) in the circulation of the 51 patients with the ectopic ACTH Syndrome. The diagnostic accuracy of the measurement of ACTH precursors was then prospectively compared with a group of 62 patients undergoing the current "gold standard" test of inferior petrosal sinus sampling (IPSS). All those patients with ACTH precursors below a diagnostic cut-off of 100 pmol/l were subsequently shown to have pituitary tumors, whereas levels of >100 pmol/l were seen in the four patients with ectopic tumors. In comparison the IPSS had a specificity of 100% but a sensitivity of 93% and for these false negative results the ACTH precursors proved diagnostically useful. Therefore measurement of ACTH precursors offers a simple non-invasive diagnostic test for the differential diagnosis of Cushing's Syndrome which compares favourably with IPSS.
促肾上腺皮质激素(ACTH)是由前体阿黑皮素原(POMC)裂解产生的,根据组织或肿瘤的加工程度,表达POMC的细胞有可能分泌多种与ACTH相关的肽。以往的色谱分析方法表明,人类外周循环中存在高分子量形式的ACTH。然而,对加工程度的定量评估需要采用能区分ACTH前体和ACTH的双位点免疫放射分析。利用这种方法,我们先前已在正常受试者的循环中鉴定出ACTH的前体(POMC和前ACTH),浓度范围为5 - 40 pmol/L,这表明正常垂体细胞中的加工过程是不完全的。本研究旨在检查导致库欣综合征的肿瘤对POMC的加工程度,以此评估其作为诊断标志物的实用性。在对86例库欣综合征患者的回顾性分析中,35例垂体肿瘤患者中有34例ACTH前体水平较低(低于100 pmol/L),ACTH前体与ACTH的平均比值为5:1,这表明这些肿瘤能将POMC相对有效地加工为ACTH。在异位库欣综合征中,垂体外肿瘤细胞不太可能如此有效地加工POMC。因此,预计循环中ACTH前体的患病率会增加,51例异位ACTH综合征患者循环中大量过量的ACTH前体(139 - 18,000 pmol/L)证实了这一点。然后,前瞻性地将ACTH前体测量的诊断准确性与一组62例正在接受当前“金标准”岩下窦采血(IPSS)检测的患者进行比较。所有ACTH前体低于诊断临界值100 pmol/L的患者随后被证明患有垂体肿瘤,而4例异位肿瘤患者的水平>100 pmol/L。相比之下,IPSS的特异性为100%,但敏感性为93%,对于这些假阴性结果,ACTH前体被证明具有诊断价值。因此,ACTH前体的测量为库欣综合征的鉴别诊断提供了一种简单的非侵入性诊断测试,与IPSS相比具有优势。